Harris Williams Advises Single Use Support GmbH on its Investment from Pall Corporation

January 14, 2021

Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised the founders of Single Use Support GmbH (SUSupport) and SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) on an investment from Pall Corporation (Pall) in SUSupport. With its single-use products and associated equipment, SUSupport defines a new standard in the management of high value liquids in biopharma and regenerative medicine. Pall will provide a significant investment and partner with SUSupport to distribute the RoSS platform which enhances Pall’s integrated solutions and will make the RoSS platform more accessible to biopharma customers around the globe. The transaction was led by Jeffery Perkins and Brad Morrison of the Harris Williams Industrials Group and Paul Hepper, Stephan Döring and Christopher Dürolf of the firm’s Healthcare & Life Sciences (HCLS) Group.

“It was a pleasure working with SUSupport and SHS on this transaction. We look forward to following this next chapter for SUSupport, a company that is pioneering new ground in the bioprocessing value chain through its innovative end-to-end solutions,” said Jeffery Perkins, a managing director at Harris Williams. “We believe Pall will be an excellent new partner for SUSupport.”

“The expertise and experience of Harris Williams’ HCLS Group and Industrials Group and their global footprint with access to the leading bioprocessing equipment companies worldwide were critical for the transaction. We are very pleased with the outcome and appreciate the great support we received from the Harris Williams team,” said Johannes Kirchmair, one of the founders of SUSupport.

SUSupport was founded in 2015 by Johannes Kirchmair and Thomas Wurm and closes the gap between downstream and the fill-and-finish process in the biopharma industry. SUSupport is industrializing an inefficient but mission critical step in bioprocessing through a single-use, bag-agnostic high value bulk drug substance (BDS) management platform. SUSupport offers a fully scalable, complete end-to-end solution of single-use consumables and equipment for filling, freezing, shipping, thawing and draining high value BDSs. Based on the significant operational and financial advantages of SUSupport’s solution, the company has won several blue-chip pharma and bioprocessing companies globally as customers.

SHS is based in Tuebingen, Germany, and invests in medical technology and life science companies with a focus on expansion financing, changes in shareholder structures and successor situations. SHS holds minority as well as majority interests. The company was founded in 1993 and has since gained extensive experience as an industry investor, which supports the growth of its portfolio companies through a network of partnerships regarding the introduction of new products, regulatory issues or entering new markets. The SHS fund’s German and international investors include professional pension insurers, retirement funds, strategic investors, funds of funds, family offices, entrepreneurs and the SHS management team. The AIFM-registered company invests up to €30 million in equity capital, and volumes exceeding this amount are implemented with a network of co-investors. SHS is currently investing from its fifth fund.

Pall is a global filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The company's engineered products enable process and product innovation and minimize emissions and waste.

Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).

The Harris Williams Industrials Group has experience across a variety of sectors, including advanced manufacturing; building products; chemicals and specialty materials; industrial technology; and packaging. For more information on the firm’s Industrials Group and other recent transactions, visit the Industrials Group’s section of the Harris Williams website.

The Harris Williams HCLS Group has experience across a broad range of sectors, including healthcare providers; payors and payor services; outsourced pharmaceutical services; medical device supply chain; healthcare IT; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams website.

Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.